References
- Brincker M. Estimate overall treatment results in acute non-lymphocytic leukemia based on age specific rates of incidence and of complete remission. Cancer Treat. Rep. 1985; 69: 5–11
- Beguin Y., Bury J., Fillet G., Lennes G. Treatment of acute non-lymphocytic leukemia in young and elderly patients. Cancer 1985; 56: 2587
- Reiffers J., Bernard P., David B. Acute non-lymphocytic leukemia in elderly patients: results of chemotherapy and prognostic factors. Haematotogica. 1983; 68: 213
- Tilly H., Castaigne S., Bourdessoule D. Low dose cytosine arabinoside treatment for acute non-lymphocytic leukemia in elderly patients. Cancer 1633.; 55
- Ellison R. R., Holland J. F., Weil M. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood. 1968; 32: 507–523
- Preisier H. D. Failure of remission induction during the treatment of acute leukemia. Med. Pediatr. Oncol. 1978; 4: 275–276
- Sebban C., Archimbaud E., Coiffier B. Treatment of acute myeloid leukemia in elderly patients. Cancer 1988; 61: 227–231
- Keating M. J., McCredie K. B., Benjamin R. S. Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of Rubidazone and Cytosine Arabinoside, Vincristine and Prednisone (ROAP). Blood. 1981; 58: 584–591
- The Toronto Leukemia Study Group Results of chemotherapy for unselected patients with acute myeloblasts leukemia: effect of exclusions on interpretation of results. The Lancet. 1986; 5, 1986, 786-788
- Walters R. S., Kantarjian H. M., Keating M. J. Intensive treatment of acute leukemia in adults 70 years of age and older. Cancer 1987; 60: 149–155
- Kahn S. B., Begg C. B., Mazza J. J. Full dose versus attenuated dose daunorubicin, Cytosine Arabinoside, and 6-Thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly. Journal of Clinical Oncology. 1984; 2, 8: 865–870
- Foon K. A., Igheboim J., Yale C., Gale R. P. Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia. Blood. 1981; 58: 467